Bristol-Myers to acquire Kosan

Bristol-Myers (NYSE:BMY) said it will acquire cancer company Kosan (NASDAQ:KOSN) in a tender offer for $5.50 per share,

Read the full 184 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE